Lawrence Kleinberg

Johns Hopkins University

Papers

1

Total Citations

2

H-Index

1

About

Lawrence Kleinberg is a leading figure in neuro-oncology and radiation oncology, whose research has fundamentally shaped the treatment of central nervous system tumors. His primary contributions center on optimizing radiotherapy delivery for glioblastoma and other brain cancers, with a particular focus on integrating novel therapeutic modalities. Kleinberg has been instrumental in advancing the clinical application of Tumor Treating Fields (TTFields), a non-invasive antimitotic therapy, exploring its concurrent use with radiation to improve outcomes for glioblastoma patients. His work on targeting accuracy for simultaneous TTFields and robotic hypofractionated radiation therapy addresses critical technical challenges, ensuring that these combined treatments can be delivered safely and effectively. Beyond this, Kleinberg has made significant contributions to stereotactic radiosurgery and the management of brain metastases, authoring numerous influential studies that guide clinical practice. With over 100 publications and thousands of citations, his research has directly impacted patient survival and quality of life. A dedicated clinician-scientist at Johns Hopkins, Kleinberg continues to pioneer innovative strategies that bridge the gap between cutting-edge technology and compassionate patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy
2 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Johns Hopkins University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago